Concepedia

James R. Apgar

JR

14

Publications

799

Citations

14

H-Index

2007

Active since

Affiliations

Pfizer (United States)(Current)

IIT@MIT

Pfizer (Ireland)

Agrivida (United States)

James R. Apgar is an author at Pfizer (United States) specializing in medicine, protein engineering, and molecular biology.

ORCID

Top concepts

Publications per year

2007–2023

14

Publications

14

<scp>AB</scp> ‐Bind: Antibody binding mutational database for computational affinity predictions

Sarah Sirin, James R. Apgar, Eric M. Bennett et al. · Protein Science · 2015 · 180 citations · Full text

, , +24

Establishing <i>in vitro in vivo</i> correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

Lindsay B. Avery, Jason Wade, Mengmeng Wang et al. · mAbs · 2017 · 97 citations · Full text

, , +21

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Adam Root, Wei Cao, Bilian Li et al. · Antibodies · 2016 · 92 citations · Full text

Engineering a thermoregulated intein-modified xylanase into maize for consolidated lignocellulosic biomass processing

Binzhang Shen, Xueguang Sun, Xiao Zuo et al. · Nature Biotechnology · 2012 · 85 citations

, , +10

Modeling Backbone Flexibility to Achieve Sequence Diversity: The Design of Novel α-Helical Ligands for Bcl-xL

Xiaoran Fu, James R. Apgar, Amy E. Keating · Journal of Molecular Biology · 2007 · 80 citations · Full text

, , +11

Rows per page

1–5 of 14